Astellas Global Health Foundation Makes Inaugural Grant to the END Fund

- First Foundation Grant Focused on Access to Health Addresses Neglected Tropical Diseases in the Democratic Republic of Congo -
Press Release

NORTHBROOK, Ill., December 10, 2019 /3BL Media/ – Today, the Astellas Global Health Foundation announced its first grant since the Foundation’s inception, awarding $750,000 to the END Fund, a prominent philanthropic organization combating neglected tropical diseases (NTDs) worldwide. The END Fund will use the investment to deliver NTD treatments through mass drug administration mechanisms designed to control and eliminate NTDs in the Democratic Republic of Congo, one of the world’s poorest countries ranking among the highest in NTD prevalence.

Astellas Brings Light to the Lives of Cancer Patients

At Astellas, we are dedicated to supporting and improving the lives of those impacted by cancer. One of the ways we provide this support is by working with patient advocacy organizations, such as The Leukemia and Lymphoma Society (LLS) – the world's largest voluntary health agency dedicated to blood cancers, including leukemia, lymphoma, Hodgkin's disease and myeloma.
Subscribe to TYO:4503